Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -319.16% is 39% above its 5-year average of -520.17%, near the high end of its 5-year range (-2797.76%–-168.72%).
14.15% below its 12-month average of -279.61%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -168.72%.
OPERATING MARGIN
-319.16%
OPERATING MARGIN AVG TTM
-279.61%
OPERATING MARGIN AVG 3Y
-454.52%
OPERATING MARGIN AVG 5Y
-520.17%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-14.15%
CURRENT VS 3Y AVG
+29.78%
CURRENT VS 5Y AVG
+38.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 782 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lucyd, Inc
Market Cap
$5.86M
Operating Margin
-319.16%
TTM Avg
-279.61%
3Y Avg
-454.52%
5Y Avg
-520.17%
Market Cap
$5.79M
Operating Margin
-6.41%
TTM Avg
-19.29%
3Y Avg
-27.48%
5Y Avg
-29.17%
Market Cap
$5.77M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.68M
Operating Margin
-9154.62%
TTM Avg
-6279.74%
3Y Avg
-3924.25%
5Y Avg
-3328.36%
Market Cap
$5.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
Market Cap
$5.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.98M
Operating Margin
-43737.46%
TTM Avg
-33857.66%
3Y Avg
-147235.02%
5Y Avg
-109633.70%
Market Cap
$6.01M
Operating Margin
-3763.78%
TTM Avg
-7261.24%
3Y Avg
-3718.32%
5Y Avg
-2490.24%
Market Cap
$5.41M
Operating Margin
0.00%
TTM Avg
-62.53%
3Y Avg
-159.78%
5Y Avg
-184.56%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lucyd, Inc (LUCY) | $5.86M | -319.16% | -279.61% | -454.52% | -520.17% |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.79M | -6.41% | -19.29% | -27.48% | -29.17% |
| enVVeno Medical Corporation (NVNO)vs › | $5.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.68M | -9154.62% | -6279.74% | -3924.25% | -3328.36% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.94M | 0.00% | 0.00% | 0.00% | -71.62% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -43737.46% | -33857.66% | -147235.02% | -109633.70% |
| Scienture Holdings, Inc. (SCNX)vs › | $6.01M | -3763.78% | -7261.24% | -3718.32% | -2490.24% |
| Pulmatrix, Inc. (PULM)vs › | $5.41M | 0.00% | -62.53% | -159.78% | -184.56% |
| Femasys Inc. (FEMY)vs › | $6.22M | -763.90% | -929.35% | -1043.46% | -924.75% |
Gross Margin
22.8%
Operating Margin
-319.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -168.72% |
| 2026-03-31 | -306.60% |
| 2025-12-31 | -260.39% |
| 2025-09-30 | -287.49% |
| 2025-06-30 | -374.82% |
| 2025-03-31 | -418.87% |
| 2024-12-31 | -314.57% |
| 2024-09-30 | -694.82% |
| 2024-06-30 | -639.61% |
| 2024-03-31 | -525.36% |
| 2023-12-31 | -412.58% |
| 2023-09-30 | -719.68% |
| 2023-06-30 | -785.20% |
| 2023-03-31 | -986.02% |
| 2022-12-31 | -2797.76% |
| 2022-09-30 | -898.75% |
| 2022-06-30 | -559.91% |
| 2022-03-31 | -503.42% |
| 2021-12-31 | -500.80% |
| 2021-09-30 | -638.05% |
| 2021-06-30 | -407.63% |
| 2021-03-31 | -184.72% |
| 2020-12-31 | -893.92% |
| 2020-09-30 | -1089.86% |
| 2020-06-30 | -1522.70% |
| 2020-03-31 | -1522.72% |
